Academic literature on the topic 'Cubensis mushroom'

A B S T R A C TIntroduction Psilocybe mushroom, or widely known as the magic mushroom is avariety of mushroom commonly consumed because of hallucinogenic traits it causestoward its consumer. This hallucinogenic effect is caused by Psilocybin, ahallucinogenic substance often found within Psilocybe mushroom. This substanceaffects mental state of the consumer and has similar effect to those of LSD andMescaline. Aside from its effect to cause mental disturbance, consumption of thismushroom may cause acute renal injury which leads to a fatal and life-threateningsituation.Case presentation: A case of Psilocybe intoxication had been reported in a22 years old male with a confirmed history of consuming Psilocybe mushroom. Patientfirst came with a symptom of disorientation and restlessness. Patient also often shookhis head off, laughed out, screamed, and continuously making bizarre movements.Psychiatric examination confirmed a sign of auditory hallucination, unstable mood,and stereotypical behavior experienced by the patient. Conclusion: An approach isneeded in the form of a physical examination and support that supports a promptand precise diagnosis, as well as comprehensive management that focuses on thedirect management of life-threatening symptoms and symptomatic treatment, takinginto account the signs and symptoms of life-threatening nephrotoxicity

A B S T R A C TIntroduction Psilocybe mushroom, or widely known as the magic mushroom is avariety of mushroom commonly consumed because of hallucinogenic traits it causestoward its consumer. This hallucinogenic effect is caused by Psilocybin, ahallucinogenic substance often found within Psilocybe mushroom. This substanceaffects mental state of the consumer and has similar effect to those of LSD andMescaline. Aside from its effect to cause mental disturbance, consumption of thismushroom may cause acute renal injury which leads to a fatal and life-threateningsituation.Case presentation: A case of Psilocybe intoxication had been reported in a22 years old male with a confirmed history of consuming Psilocybe mushroom. Patientfirst came with a symptom of disorientation and restlessness. Patient also often shookhis head off, laughed out, screamed, and continuously making bizarre movements.Psychiatric examination confirmed a sign of auditory hallucination, unstable mood,and stereotypical behavior experienced by the patient. Conclusion: An approach isneeded in the form of a physical examination and support that supports a promptand precise diagnosis, as well as comprehensive management that focuses on thedirect management of life-threatening symptoms and symptomatic treatment, takinginto account the signs and symptoms of life-threatening nephrotoxicity

Abstract Synthetic psilocybin (PSB), but also the PSB-containing mushrooms are used for psychedelic therapy and microdosing. It is necessary to know alkaloids variability and stability in wild-grown mushrooms. Concentrations of other psychotropic (or potentially psychotropic) tryptamines such as psilocin (PS), baeocystin (BA), norbaeocystin (NB), and aeruginascin (AE) are also relevant. This study aims to determine the concentrations of PSB, PS, BA, NB and AE in a large sample set of mushroom genera previously reported to contain psychotropic tryptamines. Freshly cultivated fruit bodies of Psilocybe cubensis were used for monitoring stability (including storage and processing conditions of fruiting bodies). Mycelium and the individual parts of the fruiting bodies (caps, stipes, and basidiospores) were also examined. The concentration of tryptamines was analyzed using ultra-high-performance liquid chromatography coupled with mass spectrometry. Analytical standards were synthetized in house and UHPLC-MS/MS method was fully validate for quantification of tryptamine alkaloids in mushroom samples. Most mushroom collections were documented by fungarium specimens and/or ITS rDNA/LSU/EF1-α sequencing.The tryptamine concentrations in mushrooms are extremely variable, which could possibly influence the medicinal effect compared to therapy with chemically pure PSB. The storage conditions strongly affected the alkaloids decay and showed that the highest degradation of tryptamines was seen in fresh mushrooms stored at −80° C, and the lowest decay was seen in dried biomass stored in the dark at room temperature. This study was funded by the Ministry of Health of the Czech Republic (NU21-04-00307). References GOTVALDOVA, K., BOROVICKA, J., HAJKOVA, K., CIHLAROVA, P., ROCKEFELLER, A. &KUCHAR, M. 2022. Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids. International Journal of Molecular Sciences, 23. GOTVALDOVA, K., HAJKOVA, K., BOROVICKA, J., JUROK, R., CIHLAROVA, P. &KUCHAR, M. 2021. Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis. Drug Testing and Analysis, 13, 439-446.

Squirrels and chipmunks are known to have mycophagous habits. Nonetheless, records of mycopaghy involving these animals not always present the fungal species involved, specially when they are epigeous mushrooms in Neotropical forests. Here, we report events of mycophagy involving the Brazilian squirrel (Guerlinguetus brasiliensis) and coconut mushroom (Oudemansiella cubensis), including description of the event and presenting photographs. The aim of this study is to discuss the mycophagous habit of the Brazilian squirrel.